Atlas Trials

Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographY

Clinical trial NCT05822102 · UNKNOWN

Trial details

NCT number
NCT05822102
Sponsor
National Jewish Health
Status
UNKNOWN
Study type
OBSERVATIONAL
Cystic Fibrosis
Start date
2023-02-09
Primary completion
2023-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.